SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-019301
Filing Date
2022-07-14
Accepted
2022-07-14 15:51:58
Documents
12
Period of Report
2022-07-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 82419
  Complete submission text file 0001493152-22-019301.txt   258228

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcsa-20220711.xsd EX-101.SCH 3004
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcsa-20220711_lab.xml EX-101.LAB 34240
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcsa-20220711_pre.xml EX-101.PRE 22389
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3618
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39531 | Film No.: 221083023
SIC: 2834 Pharmaceutical Preparations